← Open Payments lookup

SUSAN ENG-MA: Open Payments

NPI 1477687754 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,346 in 50 payments from 18 companies in 2025. Trend: 2023 $4,177 · 2024 $3,523 · 2025 $3,346

Food & beverage: $3,279Education: $67
CompanyPaymentsAmount
Amgen Inc.4$431
AstraZeneca Pharmaceuticals LP3$369
GlaxoSmithKline, LLC.4$312
AKEBIA THERAPEUTICS INC3$287
Boehringer Ingelheim Pharmaceuticals, Inc.3$273
Lilly USA, LLC2$250
Calliditas Therapeutics US Inc.5$227
PFIZER INC.2$215
Otsuka America Pharmaceutical, Inc.4$200
Otsuka Pharmaceutical Development & Commercialization, Inc.2$150

Products named: BENLYSTA, TAVNEOS, Vafseo, JARDIANCE, LOKELMA, TARPEYO, PREVNAR 20, REZDIFFRA.

Industry payments across NY — which companies pay providers there.